Nice work Sam but you fail to point out that KSA’s drug failed,...

Nice work Sam but you fail to point out that KSA’s drug failed, i believe ANP’s drug is going to be a winner and will eventually follow NEU’s path. Re read ANPto2dollars post and Waynesworld last post… we are addressing a possible cure for inflammation over multiple indications.. stabilisation of muscle wasting, preventing fibrosis and halting the disease progression for DMD patients has already been proven once. Please accept that the SP of all spec’s in the bio sector have been smashed due to the current global financial climate and inflation. Time for all holders to rally and support our investment and stop negative sentiment scaring away retail investors… I think Garner is a good choice, let’s give him a chance to see what he can do with a drug that actually works.. GLTA